News
2010
/
2009
/
2008
/
2007
Biotech Sweden elects editorial council
December 14, 2009
Biotech Sweden, one of the Nordic countries most read news media, elects an editorial council. The council aims to act as advisors and gather information about everything that affects the life science industry. Among the elected is A+ Science CEO, Agneta Franksson.
CME accreditation at the ESC congress
September 21, 2009
For the 6th consecutive year A+ Science has, in collaboration with the Sahlgrenska Academy at Gothenburg University, provided 3 accredited sessions of Continuing Medical Educations (CME).
Pharmacovigilance launches 24 h MD services
September 01, 2009
Due to regulatory requirements all Marketing Authorization Holders are required to have access to a safety physician 24h a day.
Försöksläkemedel kan bevara insulinproduktion vid typ 1-diabetes
June 29, 2009
Patienter söks till en läkemedelsprövning av försöksläkemedlet Otelixizumab. Otelixizumab har i tidigare prövningar visat sig kunna bevara insulinproduktionen för patienter med tidig typ 1-diabetes i upp till 48 månader.
Ny VD utsedd
June 19, 2009
In Swedish
Agneta Franksson appointed New Managing Director
June 19, 2009
Agneta Franksson has been appointed Managing Director of A + Science AB, effective on May 25. Franksson will be located at the Stockholm office and will have a strong focus on sales and marketing.
Meet us at Bio International Convention 2009
April 02, 2009
May 18-21, 2009, Monday-Thursday Atlanta, GA USA
Direct renin inhibitor Aliskiren as effective as Losartan
February 05, 2009
Results of the ALLAY* study, published in Circulation, shows that Aliskiren is as effective as Losartan in reducing LV mass. The follow-up (after 36 weeks) also showed that Aliskiren proved equally effective in lowering blood pressure.
Ledningsförändring
February 02, 2009
in Swedish
CAFE-LLA study presents principal results
January 27, 2009
Results showed that favourable effects of Statins on cardiovascular outcomes in hypertensive patients are independent of large-artery function and central pressures.
Upcoming events
About us
Contact us
News
Events
Career
History
Investor Relations
Home
Resources
About us
Contact us
Investor Relations
News
Therapeutic Areas
Gain from experience
Clinical Services
Reduce time to market
City Site
Kickstart your study
Outsourcing
Empower your team
Volunteers
Investigators
About us
Contact us
News
Events
Career
History
Investor Relations
Resources
Case Studies
Downloads
Therapeutic Areas
Oncology
Cardiovascular
Clinical Services
Phase I-IV
Medical Devices
Clinical Data Management
Biostatistics
Patient Recruitment
Regulatory
Quality Assurance
Pharmacovigilance
ECG
Continuing Medical Education (CME)
City Site
Our Research Unit
Our Research Nurses
Outsourcing
Our Consultants
Volunteers
Att vara försöksperson
Rolf berättar
Pågående studier
Investigators
Copyright © 1997-2009 A+ Science AB. or its subsidiaries. All rights reserved.